Dennis B. Meulemans
Analyst · Robert Baird
Thank you, Darby, and good afternoon. As a special note to our investors, our Form 10-Q will be filed later this evening and available tomorrow. We had another solid quarter, census up, revenues up, margins stable, income up, balance sheet remains solid. Those are the highlights, but more specifically: net service revenues from continuing operations for the quarter increased 10% to $67.3 million compared to the same period in '12. For the year, our revenues have increased 8.6% to $196.1 million, our revenue growth for the quarter has been driven by a 12.1% increase in census and a modest decline in average billable hours per consumer. Net income from continuing operations was $2.8 million, or $0.25 per diluted share, an increase of 25.7% when compared to the reported net income of $2.2 million, or $0.20 per diluted share for 2012. Gross profit margins remained stable at 25.6% of revenues when compared to the third quarter of '12, reflecting stable revenue streams and consistent expense management. General and administrative expenses increased $1.2 million, or 11.1% over the prior year amount, reflecting increased costs related to our stocks, or for our compliance efforts, legal and consulting expenses related to our M&A effort, and the roll off of our NuCare system in Illinois, in response to the state's July 1 mandate. We anticipate our G&A expenses will remain at these higher levels on a -- for the foreseeable future. We received prompt payment interests from the State of Illinois for late payments on invoices for their fiscal year ending June 30, 2013, totaling $183,000. This income was recorded as an offset to our interest expense. Income from continuing operations, but before taxes was 6.4% of revenues, a 700-basis point improvement when compared to 5.7% for the prior year period, reflecting our ability to leverage our fixed cost as the revenue base increases. This improvement came despite the increase in G&A expenses noted earlier. Our effective tax rate was 35.4%, a 900-basis point improvement over the prior year's tax rate. Our taxes continue to benefit from the amounts we will realize in 2013, related to various employee tax credit programs. We incurred a net $203,000 in expense related to the wind down of the Home Health business, or approximately $0.02 per diluted share, all recorded as discontinued operations. Now let's turn to our balance sheet and cash flow statement. Cash flow from operations during the quarter was a negative $9.1 million, reflecting the seasonal decrease in payment from the State of Illinois. If you recall, we had a large onetime payment from the State of Illinois received in late June, that positively impacted our cash flow for the second quarter. Payments from the State of Illinois continue to be stable, despite this quarterly timing issue. Our accounts receivable, net of reserves, increased $10.9 million in the quarter to $54.5 million as of September 30, 2013. At September 30, we had $29.5 million in cash on our balance sheet, no long-term debt and availability under our credit facility. Adjusted EBITDA has been refined to exclude discontinued operations, in addition to other normal adjustments. Adjusted EBITDA was $5 million in the third quarter of 2013, an increase of 8.7% from $4.6 million in 2012. We filed an S-3 shelf registration today. This universal shelf registration is part of a strategic financing plan, and is intended to provide the company with greater financial flexibility, generally, and as we evaluate future acquisitions. As normal for these offerings, certain existing shareholders are registering their shares as allowed under the registration rights agreements with the company. We have no immediate plans to issue any securities through this vehicle. We announced today 2 acquisitions, which both Mark and Darby have commented on. These 2 acquisitions represent approximately $20 million to $22 million in aggregate revenues for the calendar year ending December 31, 2013. We expect to close on these acquisitions in the fourth quarter. We do not anticipate these acquisitions will add materially to our 2013 revenues or income, but do anticipate they will be accretive to earnings in 2014. This concludes my comments. I'd like to turn the discussion back to Mark for closing remarks and for any questions.